Health Indicator Report of Cancer Incidence - Non-Hodgkin's Lymphoma
Non-Hodgkin lymphoma (NHL) refers to cancers of the lymphatic system. Each year, NHL accounts for over 4% of all new cancer cases and over 3% of all cancer deaths in the U.S. This equates to 73,000 cases and 20,000 deaths. The five-year survival rate is 71%. New Mexico has averaged about 360 new cases of NHL per year between 2010 and 2015. Improvements in the detection and diagnosis of NHL may account for some, but probably not all, of this increase. The causes of NHL are unknown, but studies have shown an association with certain chemicals that may impair the immune system, as well as certain types of viruses. The common mechanism for these factors appears to be immunosuppression.
NotesData have been age-adjusted to the U.S. 2000 standard population.
- Numerator: The New Mexico Tumor Registry, University of New Mexico Health Sciences Center, http://hsc.unm.edu/som/nmtr/.
- New Mexico Population Estimates: University of New Mexico, Geospatial and Population Studies (GPS) Program, http://gps.unm.edu/.
DefinitionNon-Hodgkin's lymphoma (NHL) incidence refers to the number of persons newly diagnosed with NHL within a specified time period. Measures include 1) the number of newly diagnosed NHL cases; and 2) age-adjusted NHL incidence rates (adjusted by the direct method to the 2000 US standard population). All rates are expressed per 100,000 persons.
NumeratorThe number of NHL cases newly diagnosed in New Mexico residents within a specified time period. The data are based on the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) program incidence site recode for NHL: 33041-33042. http://seer.cancer.gov/siterecode/
DenominatorThe estimated population of New Mexico residents during a specified time period.
Other ObjectivesCDC Environmental Public Health Tracking, Nationally Consistent Data and Measures (EPHT NCDM)
Page Content Updated On 01/09/2019, Published on 05/16/2019